Stem Cell Therapy for Peripheral Neuropathy: 2026 Evidence Review
Peripheral neuropathy affects millions, and many patients turn to stem cell therapy when standard treatments fail. This 2026 evidence review separates documented clinical trial data from preclinical research and unproven commercial claims, noting that no stem cell therapy for peripheral neuropathy is currently FDA-approved.
Stem Cell Treatment for Hair Loss: Cutting Through the Hype in 2026
Stem cell treatment for hair loss is surrounded by hype, but zero options are FDA-approved as of 2026. This guide breaks down the regulatory landscape, compares stem cells to PRP and exosomes, and highlights the real breakthroughs—like UVA’s KROX20+ research and Pelage’s PP405—shaping the field today.
Rise Regenerative Medicine: Inside Seattle’s Naturopathic Model
Rise Regenerative Medicine, led by naturopathic physician Dr. Sierra Storm, offers a unique take on regenerative care in Seattle’s Lower Queen Anne. This article breaks down the clinic’s services, philosophy, and what the 2026 regulatory landscape means for patients choosing a provider.